BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 34638338)

  • 21. Comprehensive meta-analysis of Signal Transducers and Activators of Transcription (STAT) genomic binding patterns discerns cell-specific cis-regulatory modules.
    Kang K; Robinson GW; Hennighausen L
    BMC Genomics; 2013 Jan; 14():4. PubMed ID: 23324445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transducer and activator of transcription family is a prognostic marker associated with immune infiltration in endometrial cancer.
    Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
    J Clin Lab Anal; 2022 Apr; 36(4):e24315. PubMed ID: 35244291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy.
    Chen HH; Chou CY; Wu YH; Hsueh WT; Hsu CH; Guo HR; Lee WY; Su WC
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):658-66. PubMed ID: 21300446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STAT proteins: from normal control of cellular events to tumorigenesis.
    Calò V; Migliavacca M; Bazan V; Macaluso M; Buscemi M; Gebbia N; Russo A
    J Cell Physiol; 2003 Nov; 197(2):157-68. PubMed ID: 14502555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STAT family of transcription factors in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
    Wong GL; Manore SG; Doheny DL; Lo HW
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):84-106. PubMed ID: 35995341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of STATs in transcriptional control and their impact on cellular function.
    Bromberg J; Darnell JE
    Oncogene; 2000 May; 19(21):2468-73. PubMed ID: 10851045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunolocalisation of the janus kinases (JAK)--signal transducers and activators of transcription (STAT) pathway in human epidermis.
    Nishio H; Matsui K; Tsuji H; Tamura A; Suzuki K
    J Anat; 2001 May; 198(Pt 5):581-9. PubMed ID: 11430697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.
    Szelag M; Czerwoniec A; Wesoly J; Bluyssen HA
    PLoS One; 2015; 10(2):e0116688. PubMed ID: 25710482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JAK-STAT core cancer pathway: An integrative cancer interactome analysis.
    Erdogan F; Radu TB; Orlova A; Qadree AK; de Araujo ED; Israelian J; Valent P; Mustjoki SM; Herling M; Moriggl R; Gunning PT
    J Cell Mol Med; 2022 Apr; 26(7):2049-2062. PubMed ID: 35229974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mining the prognostic significance and immune infiltration of
    Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
    Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS; Meyer DJ; Billestrup N; Norstedt G; Schwartz J; Carter-Su C
    Mol Endocrinol; 1996 May; 10(5):519-33. PubMed ID: 8732683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies.
    Rah B; Rather RA; Bhat GR; Baba AB; Mushtaq I; Farooq M; Yousuf T; Dar SB; Parveen S; Hassan R; Mohammad F; Qassim I; Bhat A; Ali S; Zargar MH; Afroze D
    Front Pharmacol; 2022; 13():821344. PubMed ID: 35401182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pan-cancer analysis of the expression of STAT family genes in tumors and their relationship to the tumor microenvironment.
    Zhou M; Zhang P; Da M; Yang R; Ma Y; Zhao J; Ma T; Xia J; Shen G; Chen Y; Chen D
    Front Oncol; 2022; 12():925537. PubMed ID: 36176415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression.
    Dokduang H; Techasen A; Namwat N; Khuntikeo N; Pairojkul C; Murakami Y; Loilome W; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 Oct; 21(10):767-76. PubMed ID: 25044480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoexpression analysis of selected JAK/STAT pathway molecules in patients with non- small-cell lung cancer.
    Pastuszak-Lewandoska D; Domańska-Senderowska D; Kordiak J; Antczak A; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Kiszałkiewicz JM; Brzeziańska-Lasota E
    Pol Arch Intern Med; 2017 Nov; 127(11):758-764. PubMed ID: 28972958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Stat family in cytokine signaling.
    Ihle JN
    Curr Opin Cell Biol; 2001 Apr; 13(2):211-7. PubMed ID: 11248555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signal Transducer and Activator of Transcription (STATs) Proteins in Cancer and Inflammation: Functions and Therapeutic Implication.
    Loh CY; Arya A; Naema AF; Wong WF; Sethi G; Looi CY
    Front Oncol; 2019; 9():48. PubMed ID: 30847297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung cancer treatment potential and limits associated with the STAT family of transcription factors.
    Faida P; Attiogbe MKI; Majeed U; Zhao J; Qu L; Fan D
    Cell Signal; 2023 Sep; 109():110797. PubMed ID: 37423343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. STAT proteins: novel molecular targets for cancer drug discovery.
    Turkson J; Jove R
    Oncogene; 2000 Dec; 19(56):6613-26. PubMed ID: 11426647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The predictive value of prognosis and therapeutic response for STAT family in pancreatic cancer.
    He Z; Zhang X; Wang S; Dai X; Wang Q; Lu Q; Lu H; Wu Y; Wang H; Wang X; Wang H; Liu Y
    Heliyon; 2023 May; 9(5):e16150. PubMed ID: 37215832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.